Felipe Zerwes

15PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersModels of care and place of birthLiquid biopsiesCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 13, 2026
Immune profiling in residual disease: refining risk stratification after neoadjuvant therapy in HER2-positive breast cancer.

Marcelo Antonini, André Mattar, Francisco Pimentel Cavalcante

|Dec 12, 2025
Clinical characteristics and prognostic impact of HER2 low expression in breast cancer subtypes from a Brazilian real-world cohort.

André Mattar, Marcelo Antonini, Francisco Pimentel Cavalcante

|Jul 12, 2025
Is axillary surgery still justified in DCIS diagnosed via vacuum-assisted biopsy?

Marcellus do Nascimento Moreira Ramos, André Mattar, Marcelo Antonini

|Mar 27, 2025
Comparative Analyses of Van Nuys Prognostic Index and NCCN Guidelines in Ductal Carcinoma <i>In Situ</i> Treatment in a Brazilian Hospital.

Marcelo Antonini, Raissa Barros Vasconcelos, André Mattar

|Mar 17, 2025
Oncological outcomes of breast-conserving surgery versus mastectomy following neoadjuvant chemotherapy in a contemporary multicenter cohort.

Francisco Pimentel Cavalcante, Felipe Pereira Zerwes, Ryane Alcantara

Pageof 3